4 results
To assess the bioequivalence of two marketed formulations of ribavirin (ribavirin solution and capsules).
To investigate the potential of an interaction between 4 mg/kg and 16 mg/kg sugammadex and enoxaparin or UFH on anticoagulant activity in young healthy male volunteers.
To evaluate the safety and efficacy of the REG1 Anticoagulation System in Acute Coronary Syndrome patients undergoing cardiac catheterization by determination of the clinically acceptable dose range of RB007, which can be used to reliably reverseā¦
The main objective of the current proof-of-concept study is to explore the feasibility, acceptance and potential (clinical) added value of Sense-IT in a sample of psychiatric patients with ASD/ID/BPD and their psychiatric nurses.